W. Middlekauff

W. Middlekauff

No open positions remaining

Net worth: 253 250 $ as of 31/05/2026

65 year
Health Technology
Commercial Services
Consumer Services

Profile

W.
Bradford Middlekauff
is currently an Independent Director at Amanat Acquisition Corp.
since 2026 and Chief Business Officer & General Counsel at Tourmaline Sub, Inc. since 2022.
Former positions include Chairman at Biotechnology Innovation Organization, Director at SpliceBio SL, Senior Vice President-Strategic Planning at Medarex, Inc. from 2000 to 2008, VP-Business Development & General Counsel at Algos Pharmaceutical Corp.
from 1998 to 2000, Secretary, Chief Legal Officer & General Counsel at Kolltan Pharmaceuticals, Inc. from 2008 to 2013, Secretary, Senior Vice President & General Counsel at Edge Therapeutics, Inc., Associate at Cooley Godward LLP from 1993 to 1998, Secretary & Chief Legal Officer at PDS Biotechnology Corp.
in 2019, General Counsel at Immunovant, Inc. from 2019 to 2020, Chief Legal Officer at Castle Creek Biosciences, Inc. from 2021 to 2022, and Secretary & Chief Business Officer at Tourmaline Bio, Inc. from 2023 to 2025.
Education includes undergraduate studies at Brown University and graduate studies at Yale Law School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
1.15%
20/05/2026 25,000 ( 1.15% ) 253 250 $ 31/05/2026

W. Middlekauff active positions

CompaniesPositionStart
General Counsel 01/06/2022

Former positions of W. Middlekauff

CompaniesPositionEnd
General Counsel 01/05/2022
IMMUNOVANT, INC. General Counsel 01/11/2020
PDS BIOTECHNOLOGY CORPORATION General Counsel 12/04/2019
General Counsel 01/08/2013
See the detail of W. Middlekauff's experience

Training of W. Middlekauff

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

57

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. W. Middlekauff